Accounting & Financial Management
Year-end financials are being watched closely as the healthcare system gets a handle on the full impact of COVID-19.
The organization still managed a $3.1 billion profit for the year, a significant 25% increase from 2019.
Budgets continue to be impacted by the increased use of high-cost drugs and critical care drugs for coronavirus patients.
Patients feel that customer experience is an important part of their healthcare journey, and a key reason to stay with a provider or abandon it.
Most feel that healthcare costs will continue to rise over the next couple of years despite a Democratic Senate majority.
Some organizations use up to four vendors, each of whom handles different components of the revenue cycle process.
The numbers speak to the struggles the healthcare industry faces as it remains in the midst of the battle against the coronavirus.
Getting paid has become imperative during a time when both hospitals and patients may be cash-strapped.
The mark was propelled by strong IPO environment and robust private merger and acquisition activity.
The numbers don't necessarily reflect worse performance among system-affiliated groups, but rather a different mix of expenses and services.